-
Addition of serplulimab to chemotherapy extends OS in small cell lung cancer
31 Jan 2023 00:54 GMT
… extensive-stage small cell lung cancer, according to randomized phase … for approximately 15% of lung cancer cases. Most patients present … extensive-stage small cell lung cancer. The analysis included 585 … 3 weeks, plus IV carboplatin and etoposide every 3 …
-
Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer
30 Jan 2023 09:43 GMT
… IIIA non-small cell lung cancer. Unfortunately, many of … with non-small cell lung cancer following surgery and adjuvant … with non-small cell lung cancer.”
"With this approval … aberrations; in combination with carboplatin and either paclitaxel or …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:12 GMT
… non-small cell lung cancer following surgery and … (ETOP).
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … with neoadjuvant chemotherapy (carboplatin and paclitaxel followed …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:06 GMT
… non-small cell lung cancer following surgery and … (ETOP).
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … with neoadjuvant chemotherapy (carboplatin and paclitaxel followed …
-
Immutep Quarterly Activities Report
30 Jan 2023 13:00 GMT
… 1st line non-small cell lung cancer (1L NSCLC)
Compelling Phase II … chemotherapy agent which is oxaliplatin, carboplatin, or topotecan. They follow the …
-
US FDA approves Keytruda as adjuvant treatment following surgical resection and platinum─based chemotherapy for patients with stage IB (T2a =4 centimeters), II, or IIIA NSCLC
30 Jan 2023 07:49 GMT
… non-small cell lung cancer following surgery and … ; in combination with carboplatin and either paclitaxel or … Oncology Platform (ETOP).
Lung cancer is the leading cause … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer …
-
Synthesis of Gingerol-Metals Complex and in-vitro Cytotoxic Activity on Human Colon Cancer Cell Line
27 Jan 2023 13:06 GMT
… , and cisplatin or derivatives like carboplatin or oxaliplatin are used to … pancreatic cancer cell PANC-1, lung cancer cells H1299 and breast cancer …
-
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy in First-Line Advanced or Unresectable Biliary Tract Cancer in KEYNOTE-966 Trial
25 Jan 2023 11:55 GMT
… resection.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination … nonsquamous non-small cell lung cancer (NSCLC), with no … KEYTRUDA, in combination with carboplatin and either paclitaxel or … with neoadjuvant chemotherapy (carboplatin and paclitaxel followed by …
-
Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Enzalutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer to Stop for Futility
25 Jan 2023 11:55 GMT
… resection.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination … nonsquamous non-small cell lung cancer (NSCLC), with no … KEYTRUDA, in combination with carboplatin and either paclitaxel or … with neoadjuvant chemotherapy (carboplatin and paclitaxel followed by …
-
Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-2056 in HER2-Expressing Tumors
25 Jan 2023 13:00 GMT
… , colorectal and non-small-cell lung cancers. The dose escalation and dose … evaluating UpRi in combination with carboplatin; and UP-NEXT, a Phase …
About
© 1995-2023